logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
PBYI
Puma Biotechnology, Inc.
8.58
2 x 3.46
2 x 10.00
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd44.20%
1y147.26%
8.58
day range
8.69
3.03
52 week range
8.75
Open8.58Prev Close8.58Low8.58High8.69Mkt Cap436.72M
Vol8.28KAvg Vol305.35KEPS0.61P/E14.07Forward P/E11.71
Beta1.20Short Ratio5.09Inst. Own67.74%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg7.54200-d Avg6.481yr Est4.33

PBYI News

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's

benzinga.com
Puma Biotechnology Sees Q2 Sales $52.000M-$55.000M vs $52.000M Est

Second Quarter and Full Year 2026 Financial Outlook Second Quarter2026NewFull Year 2026PriorFull Yea
benzinga.com
Puma Biotechnology Raises FY2026 Sales Guidance from $214.000M-$221.000M to $222.000M-$229.000M vs $

Second Quarter and Full Year 2026 Financial Outlook Second Quarter2026NewFull Year 2026PriorFull Yea
benzinga.com
Puma Biotechnology Q1 Adj. EPS $(0.04) Beats $(0.13) Estimate, Sales $44.800M Beat $42.000M Estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.04) per share which beat the analy

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
UPDATE: Puma Biotechnology Sees FY2026 Sales $214.000M-$221.000M vs $220.000M Est

Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000 million-$221.000 million vs $220.000

benzinga.com
UPDATE: Puma Biotechnology Q4 Adj. EPS $0.29 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Esti

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.29 per share which beat the analy
benzinga.com
Puma Biotechnology Sees Q1 Sales $38.000M-$42.000M vs $49.000M Est

Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $38.000 million-$42.000 million vs $49.000 million
benzinga.com
Puma Biotechnology Sees FY2026 Sales $214.000-$221.000M vs $220.000M Est

Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000-$221.000 million vs $220.000 million

Puma Biotechnology Q4 Earnings Report: What Investors Need to Know
benzinga.com
Puma Biotechnology Q4 Earnings Report: What Investors Need to Know
benzinga.com
Puma Biotechnology Q4 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.30 per share which beat the analy

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026
benzinga.com
Puma Biotechnology Added To Nasdaq Biotechnology Index, Effective Dec. 19

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been add
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Puma Biotechnology Raises FY2025 Sales Guidance from $212.000M-$222.000M to $220.000M-$223.000M vs $

Puma Biotechnology (NASDAQ:PBYI) raises FY2025 sales outlook from $212.000 million-$222.000 million

benzinga.com
Puma Biotechnology Sees Q4 Sales $67.000M-$70.000M vs $66.600M Est

Puma Biotechnology (NASDAQ:PBYI) sees Q4 sales of $67.000 million-$70.000 million vs $66.600 million
benzinga.com
Puma Biotechnology Q3 Adj. EPS $0.21 Beats $0.04 Estimate, Sales $54.500M Beat $51.000M Estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.21 per share which beat the analy

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025
benzinga.com
Puma Biotechnology Affirms FY2025 Sales Guidance of $212.000M-$222.000M vs $217.800M Est

Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million
benzinga.com
Puma Biotechnology Sees Q3 Sales $48.000M-$51.000M vs $60.000M Est

Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million
benzinga.com
Puma Biotechnology Q2 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $49.20M Miss $50.75M Estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analy
benzinga.com
Earnings Scheduled For August 7, 2025
benzinga.com
Earnings Scheduled For May 8, 2025
benzinga.com
Earnings Scheduled For February 27, 2025
benzinga.com
Earnings Scheduled For November 4, 2021

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday